| |
|
|
|
-, Sheraton San Diego Hotel & Marina, San Diego, CA
October 18-21, 2004
The re-emergence of ion channels as drug targets have sparked intensive research efforts on potassium, sodium and calcium targets for drug discovery. At this year’s 3rd International Ion Channel Drug Targets event, we take a step further and look at validating the therapeutic utilities of these and other emerging ion channel targets, particularly in the areas of pain, CNS and peripheral diseases. The 3rd International Ion Channel Drug Targets conference is part of ACT 2004, an event that ties together 4 conferences with a unified exhibit floor. Each conference in ACT offers a unique program for the industry involved, while presenting one exhibit hall with technologies and services that cut across the 4 sectors. To register for Ion Channel Drug Targets, visit www.IBCLifeSciences.com/3043. For information on the 3 other conferences at the ACT event, visit www.IBCLifeSciences.com/ACT.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
Keynote Speakers: Reinhold Penner, M.D., Ph.D., University of Hawaii
Berti Hille, Ph.D., University of Washington School of Medicine
D. Lansing Taylor, Ph.D., Cellumen, Inc.
Ralph Garippa, Ph.D., Hoffmann-La Roche, Inc.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Phone: (508) 616-5550 x1004
Fax: (508) 616-5522
Email: reg@ibcusa.com
Online: www.IBCLifeSciences.com/3043
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|